Synuclein proteins and Alzheimer's disease

Area of Science:

• Neuroscience
• Pathology
• Biochemistry

Background:

• Alzheimer's disease (AD) is characterized by the degeneration of presynaptic cholinergic nerve terminals.
• Beta-amyloid (Aβ) fibrils form senile plaques, a hallmark of AD pathology.
• The role of synuclein/NAC proteins in AD pathogenesis is not fully understood.

Purpose of the Study:

• To investigate the presence and role of synuclein/NAC proteins in Alzheimer's disease.
• To explore the potential link between synuclein/NAC proteins, cholinergic nerve terminal degeneration, and beta-amyloid plaque formation.

Main Methods:

• Immunohistochemical analysis of post-mortem Alzheimer's disease brain tissue.
• Biochemical assays to detect synuclein/NAC protein aggregation and localization.
• Correlation analysis between synuclein/NAC protein levels and neuropathological markers.

Main Results:

• Synuclein/NAC proteins were found in degenerating presynaptic cholinergic nerve terminals in Alzheimer's disease brains.
• Synuclein/NAC proteins were closely associated with beta-amyloid fibrils within senile plaques.
• The distribution of synuclein/NAC proteins correlated with the extent of cholinergic nerve terminal loss and plaque burden.

Conclusions:

• Synuclein/NAC proteins represent a potential molecular link between cholinergic neurodegeneration and beta-amyloid plaque formation in Alzheimer's disease.
• These proteins may play a significant role in the early development and progression of Alzheimer's disease pathology.